Health Care Professional Experiences and Opinions on Depression and Suicide in People With Diabetes.

depression suicidal ideation suicide type 1 diabetes type 2 diabetes

Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
10 May 2023
Historique:
medline: 10 5 2023
pubmed: 10 5 2023
entrez: 10 5 2023
Statut: aheadofprint

Résumé

People with diabetes have an increased risk of depression, intentional self-injury and self-harm (ISI), and suicide compared with the general population. This study aimed to explore experiences and awareness of health care professionals (HCPs) regarding depression, ISI, and suicide, and understand resource use and needs among HCPs who care for persons with diabetes (PWD). Health care professionals who see children and/or adults with type 1 diabetes or type 2 diabetes anonymously completed an online survey about their experiences, opinions, barriers, and needs surrounding identification and care of PWD with depression, ISI, and suicide. One hundred twenty-nine HCPs participated. The majority were medical doctors (MDs) or advanced practice providers (APPs). Only a quarter of MDs and APPs felt very comfortable asking about ISI or suicidal ideation (SI), whereas 20% felt they had received appropriate training to support those with ISI or SI. The primary needs reported include more training on how to ask, respond, and support those expressing ISI and SI. Health care professionals reported wanting better access to resources for PWD. The HCPs tend to underestimate SI in the diabetes population and rates of training were low. Areas to address include providing education and training to HCPs to improve identification and management of ISI and suicide

Identifiants

pubmed: 37162023
doi: 10.1177/19322968231171616
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19322968231171616

Auteurs

Shideh Majidi (S)

Division of Endocrinology, Children's National Hospital, Washington, DC, USA.
Barbara Davis Center for Diabetes, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

Lauren Cohen (L)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Richard I G Holt (RIG)

Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Mark Clements (M)

Pediatrics, Endocrinology, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.

Simon O'Neill (S)

Health Intelligence and Professional Liaison, Diabetes UK, London, UK.

Eric Renard (E)

Department of Endocrinology and Diabetes, Montpellier University Hospital, and Institute of Functional Genomics, CNRS, INSERM, University of Montpellier, Montpellier, France.

Doug Tynan (D)

Jefferson Medical College, Philadelphia, PA, USA.

Diana Naranjo (D)

Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.

Laurel H Messer (LH)

Barbara Davis Center for Diabetes, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

David C Klonoff (DC)

Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.

Katharine Barnard-Kelly (K)

Barnard Health Research Limited, Fareham, UK.

Classifications MeSH